FOXP3 and head and neck squamous cell carcinoma: In HNSCC, Tregs have been associated with immunosuppression, anti-inflammatory cytokine production, and therapeutic resistance (33, 59–61); however, increased densities of FoxP3+ Tregs in HNSCC has also been linked with improved therapeutic outcomes for treated patients (62–64).